Five-Year Survival Outcomes From the PACIFIC Trial: Durvalumab After Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer.
- Resource Type
- journal article
- Authors
- Spigel, David R; Faivre-Finn, Corinne; Gray, Jhanelle E; Vicente, David; Planchard, David; Paz-Ares, Luis; Vansteenkiste, Johan F; Garassino, Marina C; Hui, Rina; Quantin, Xavier; Rimner, Andreas; Wu, Yi-Long; Özgüroğlu, Mustafa; Lee, Ki H; Kato, Terufumi; de Wit, Maike; Kurata, Takayasu; Reck, Martin; Cho, Byoung C; Senan, Suresh
- Source
- Journal of Clinical Oncology; 4/20/2022, Vol. 40 Issue 12, p1301-1311, 11p
- Subject
- Language
- ISSN
- 0732183X